Welcome to our dedicated page for DUCOMMUN /DE/ SEC filings (Ticker: DCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on DUCOMMUN /DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into DUCOMMUN /DE/'s regulatory disclosures and financial reporting.
Ducommun (DCO) insider activity: Senior Vice President, Electronics & Structural Systems, executed an open‑market sale of common stock. On 11/10/2025, 1,594 shares were sold at $93.83 per share. Following this transaction, beneficial ownership stands at 67,269 shares. The ownership total includes 86 common shares acquired on July 31, 2025 through the company’s Employee Stock Purchase Plan. The filing notes the shares were sold at the exact price indicated.
A Form 144 notice for Ducommun (DCO) indicates an intent to sell 2,488 common shares with an aggregate market value of $239,594, approximately on 11/11/2025, on the NYSE through Charles Schwab. The shares to be sold were acquired via employee compensation on 03/24/2020 (2,300 shares) and 03/19/2020 (188 shares).
Recent activity disclosed includes sales during the past three months: 2,600 shares on 08/12/2025 for $267,391.18, 800 shares on 08/13/2025 for $74,897.79, and 100 shares on 08/15/2025 for $9,145.00. The filing lists 14,946,052 shares outstanding.
Ducommun (DCO) filed a Form 144 indicating an intended sale under Rule 144 of up to 1,594 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $149,557.05. The shares are planned to be sold on or about November 10, 2025 on the NYSE.
The seller’s shares were acquired as restricted stock from the issuer on three dates: 516 shares on 02/17/2022, 537 shares on 02/17/2023, and 541 shares on 02/17/2024. Shares outstanding were 14,946,052; this is a baseline figure, not the amount being sold.
Ducommun Incorporated filed a current report to note that it issued a press release on November 6, 2025. The company states that the release is provided as Exhibit 99.1 to the report. Ducommun’s common stock, with a par value of $0.01 per share, trades on the New York Stock Exchange under the symbol DCO.
Ducommun Incorporated reported Q3 2025 results marked by a large legal charge tied to its Guaymas facility fire. The company recorded $151.4 million in litigation settlement and related costs, net of insurance, resulting in an operating loss and a net loss of $64.4 million (basic and diluted loss per share $4.30). The settlement includes a $150.0 million payment, with $56.0 million expected from insurance and recorded as a receivable.
Revenue was $212.6 million, up from $201.4 million a year ago, driven by Military and space, while Commercial aerospace softened. Year-to-date revenue reached $608.9 million. Operating cash flow was $41.3 million. Cash stood at $50.9 million, and total debt was $228.1 million with a weighted-average interest rate of 6.11%.
Contract assets rose as production advanced, and remaining performance obligations totaled $1,031.2 million, with an estimated 70% recognizable as revenue over the next 12 months. Shareholders’ equity was $649.0 million at quarter-end.
Ducommun Incorporated filed a Current Report on Form 8-K reporting a material event: a Confidential Binding Term Sheet between Williams International Co., LLC and Ducommun subsidiaries — Ducommun Incorporated, Ducommun Aerostructures, Inc., and Ducommun Aerostructures Mexico, LLC dated October 3, 2025. The filing references the company’s unaudited condensed consolidated financial statements for the quarter ended June 28, 2025, which were included in the Quarterly Report filed on August 7, 2025. The 8-K was signed on October 9, 2025 by the company’s Vice President, General Counsel and Corporate Secretary.
The document is terse and describes the existence of the term sheet but provides no commercial terms, financial amounts, or definitive agreement details. Because the term sheet is confidential, material commercial impacts, timing, and financial consequences are not disclosed within this filing.
Dimensional Fund Advisors LP reported beneficial ownership of 858,779 shares of Ducommun Inc common stock, representing 5.8% of the class. The filing states these shares are owned by funds managed or advised by Dimensional and that Dimensional disclaims beneficial ownership of the securities held by those funds. Of the reported shares, Dimensional holds sole voting power over 845,468 shares and sole dispositive power over 858,779. The filing clarifies the position is held in the ordinary course of business and not for the purpose of changing or influencing control of Ducommun.
Ducommun Inc. insider sale by Suman B. Mookerji. The company reported that Suman B. Mookerji, who serves as Senior Vice President and Chief Financial Officer and is a director, sold 359 shares of Ducommun common stock on 08/29/2025 at a price of $91.22 per share. After the transaction, Mookerji beneficially owned 41,759 shares directly. The filing explains the 359-share disposition represents shares surrendered to satisfy tax withholding related to the vesting of 667 restricted stock units on August 29, 2025.
Ducommun Incorporated (DCO) submitted a Form 144 proposing the sale of 3,500 common shares through Charles Schwab with an aggregate market value of $317,275.00. The filing reports 14,923,743 shares outstanding and lists the approximate date of sale as 08/12/2025 on the NYSE. The filer states the 3,500 shares were acquired in an open-market purchase on 03/24/2020 and paid for in cash. The filing also discloses two recent sales by the Stephen Oswald & Regina Oswald Foundation totaling 517 shares in May and June 2025 for combined gross proceeds of $35,845.89. The filer represents they know of no undisclosed material adverse information.
Ducommun (DCO) Q2 FY25 10-Q—key takeaways
- Net revenue rose 2.7% YoY to $202.3 m, led by Military & Space +16%; Commercial Aerospace -10% and Industrial -23% weighed.
- Gross margin gained 50 bp to 26.6%; operating margin climbed to 8.5% (7.1% LY) as restructuring expense fell to $0.6 m.
- Net income grew 62% to $12.6 m; diluted EPS $0.82 vs $0.52. Six-month EPS $1.52 (+57%).
- Operating cash flow improved sharply to $23.2 m (vs $1.8 m). Capex $9.1 m, free cash flow positive $14.1 m.
- Debt paid down $12 m; net debt now ~$194 m. Weighted average interest rate 6.11% after SOFR swaps; hedge MTM cut OCI by $3.9 m YTD.
- Electronic Systems revenue +8.6% to $110.2 m; Structural Systems -3.7% to $92.0 m.
- Remaining performance obligations $906 m; ~70% expected to convert within 12 months.
- Berryville (AR) facility sale generated $1.2 m gain; 2022 restructuring nearing completion—$1.0 m charges YTD, $0.5–1 m yet to come.
Liquidity remains solid with $37 m cash and $200 m unused revolver; all covenants met. Management expects minimal P&L impact from the July 2025 OBBBA tax changes.